Inactive Instrument
Quotes Celltrion, Inc. Korea S.E.
Stocks
068270
KR7068270008
Biotechnology & Medical Research
|
End-of-day quote
Korea S.E.
|
||
| - KRW | - |
|
| 08-25 | Celltrion Launches Omlyclo 300 Mg Strength In Key European Markets | CI |
| 08-24 | Celltrion Submits Marketing Application for Keytruda Biosimilar in South Korea | MT |
Stock exchange
Korea S.E.
068270 - ₩
-
0
₩
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| A068270 | 189,600.00KRW | -2.27% | 67.95B ₩ |
Basic data
Market Cap (KRW)
45,911,763,361,478
Market Cap (USD)
33,230,143,643
Net sales (KRW)
4,162
Net sales (USD)
3
Free-Float
60.59 %
Free-Float capitalization (KRW)
25,921,786,837,462
Free-Float capitalization (USD)
18,761,742,896
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 33.23B | |
| -0.29% | -0.81% | +3.12% | +23.53% | 51.14B | |
| +2.65% | +4.45% | +481.36% | +567.32% | 47.4B | |
| +0.33% | +2.47% | +38.97% | +19.80% | 43.19B | |
| -0.88% | +0.90% | +24.11% | +87.74% | 42.35B | |
| -2.27% | -3.02% | +14.22% | +51.50% | 33.23B | |
| -1.21% | -0.17% | +29.16% | +135.38% | 17.07B | |
| -0.36% | -2.14% | - | - | 16.38B | |
| -0.30% | -0.08% | +12.25% | +28.50% | 14.76B | |
| +0.44% | +1.70% | +82.07% | +47.92% | 14.15B | |
| Average | -0.21% | +0.63% | +85.66% | +120.21% | 31.29B | |
| Weighted average by Cap. | -0.04% | +1.04% | +106.32% | +143.52% |
Historical Quotes: Celltrion, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- A068270 Stock
- 068270 Stock
- Quotes Celltrion, Inc.
Select your edition
All financial news and data tailored to specific country editions
